Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020672 (
hypothermia
)
17,327
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adenosine can induce
hypothermia
, as previously demonstrated for adenosine A1 receptor (A1AR) agonists. Here we use the potent, specific
A3AR
agonists MRS5698, MRS5841, and MRS5980 to show that adenosine also induces
hypothermia
via the
A3AR
. The hypothermic effect of
A3AR
agonists is independent of A1AR activation, as the effect was fully intact in mice lacking A1AR but abolished in mice lacking
A3AR
.
A3AR
agonist-induced
hypothermia
was attenuated by mast cell granule depletion, demonstrating that the
A3AR
hypothermia
is mediated, at least in part, via mast cells. Central agonist dosing had no clear hypothermic effect, whereas peripheral dosing of a non-brain-penetrant agonist caused
hypothermia
, suggesting that peripheral
A3AR
-expressing cells drive the
hypothermia
. Mast cells release histamine, and blocking central histamine H1 (but not H2 or H4) receptors prevented the
hypothermia
. The
hypothermia
was preceded by hypometabolism and mice with
hypothermia
preferred a cooler environmental temperature, demonstrating that the hypothermic state is a coordinated physiologic response with a reduced body temperature set point. Importantly,
hypothermia
is not required for the analgesic effects of
A3AR
agonists, which occur with lower agonist doses. These results support a mechanistic model for
hypothermia
in which
A3AR
agonists act on peripheral mast cells, causing histamine release, which stimulates central histamine H1 receptors to induce
hypothermia
. This mechanism suggests that
A3AR
agonists will probably not be useful for clinical induction of
hypothermia
.
...
PMID:Peripheral Adenosine A3 Receptor Activation Causes Regulated Hypothermia in Mice That Is Dependent on Central Histamine H1 Receptors. 2660 37
Administration of the nucleoside adenosine has been shown to induce
hypothermia
in a number of species, an effect mediated predominantly by the adenosine 1 receptor (A1AR) subtype. The present experiments were performed to explore the possibility that the rise of intracellular adenosine levels expected to accompany adenosine administration may contribute to the hypothermic effect of adenosine independent of A1AR activation. Since phosphorylation of adenosine by adenosine kinase (ADK) is causal in the maintenance of low intracellular adenosine, we have examined the effect of ADK inhibition on core body temperature (CBT). Our data show that inhibition of ADK by A-134974 causes a long-lasting deep
hypothermia
in wild-type mice. Since there was an about 4-fold increase of adenosine plasma levels, experiments were repeated in A1AR-/- mice. ADK inhibition caused deep
hypothermia
despite the absence of A1AR, although the effect was significantly reduced compared to WT. Furthermore, the dose-dependent
hypothermia
caused by adenosine administration in WT mice was found to be reduced, but not abolished in A1AR-/- mice. To assess the possible role of A2AR and
A3AR
activation in our experimental setting, we compared the effects of the agonists CPA (A1AR), CGS21680 (A2AR), and IB-MECA (
A3AR
) on CBT.
Hypothermia
induced by CPA was much greater than that caused by CGS21680 or IB-MECA indicating that A1AR activation is the major receptor-dependent pathway for adenosine-induced
hypothermia
under our experimental conditions. Induction of deep
hypothermia
by inhibition of ADK, maintenance of this effect in A1AR-/- mice, and maintenance of adenosine-induced
hypothermia
in A1AR-deficient mice suggest that a receptor-independent action of adenosine requiring intact function of adenosine kinase contributes importantly to the
hypothermia
induced by adenosine.
...
PMID:Profound hypothermia after adenosine kinase inhibition in A1AR-deficient mice suggests a receptor-independent effect of intracellular adenosine. 2797 40